Breaking News

Financial Report: Patheon

March 8, 2013

Banner acquisition boosts revenues

1Q Revenues: $213.5 million (+39%)
1Q Loss: $51.4 million (loss of $19.3 million 1Q12)
Comments: Banner contributed $23.3 million to growth in the quarter. Patheon standalone revenues grew 24%. CMO revenues increased 47% to $180.1 million. Pharmaceutical Development Services' (PDS) revenues increased 7% to $33.4 million. The increase in loss was due to costs associated with the Banner acquisition and related refinancing.
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks